To determine the in vivo therapeutic utility of our C-terminus Shh antibody, we injected either Ab 1C11-2G4 or control IgG antibodies into the tumors of mice bearing A549-derived NSCLC xenografts. Here, SHH is linked to non-small cell lung carcinoma.